69 results
Page 3 of 4
6-K
EX-99.1
cbn 1cy4qmyv
31 Mar 23
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
8:36am
S-8
ddkqyp1zw05t4idg3 hu
31 Mar 23
Registration of securities for employees
7:36am
S-8
7u1kn9
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-99.2
8wmhyn8wbbc4hulz
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-5.1
5kxbbiugi
31 Mar 23
Registration of securities for employees
7:36am
S-8
EX-99.1
l5ba8z7px vh0gk6r6t
31 Mar 23
Registration of securities for employees
7:36am
F-1
os8ove8nnvb1 x33uwkf
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.15
5kq6yip
19 Dec 22
Registration statement (foreign)
6:22pm
F-1
EX-10.13
la1kjol0hq
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
ryzx1n8if2d2dkenms
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
6-K
EX-10.1
fxx7bzcc
19 Dec 22
NewAmsterdam Announces Appointment of David Topper as Chief Financial Officer
4:23pm
20-F
EX-15.1
rabiw8blu8juj
28 Nov 22
Annual report (foreign)
4:41pm
20-F
uijc8jegmlz6
28 Nov 22
Annual report (foreign)
4:41pm
20-F
EX-4.16
3vp0do6z
28 Nov 22
Annual report (foreign)
4:41pm
6-K
EX-2.1
1s009y
23 Nov 22
Current report (foreign)
4:36pm
424B3
wjw9mxf
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
qyudj
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
EX-10.14
v8rkn2 c4
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
tc916u4
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm